MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Non-motor Scales"

  • MDS Virtual Congress 2020

    Non-motor Symptoms in Advanced- vs Non-advanced Parkinson’s Disease: A Subgroup Analysis of the OBSERVE-PD Observational Study

    A. Fasano, L. Bergmann, V. SC Fung, K. Onuk, K. Seppi, Z. Pirtosek (Toronto, ON, Canada)

    Objective: To report intercountry differences in non-motor symptoms in patients with advanced Parkinson’s Disease (APD) vs non-APD. Background: There is no standard criteria for the…
  • MDS Virtual Congress 2020

    RBD and autonomic dysfunction in newly diagnosed Parkinson’s disease patients

    G.M Riboldi, L. Pan, K. dePaiva Lopes, K. Watkins, T. Raj, U. Kang (New York, NY, USA)

    Objective: To determine whether newly diagnosed Parkinson’s disease (PD) patients with REM sleep behavior disorder (RBD) are more likely to have symptoms of autonomic dysfunction.…
  • MDS Virtual Congress 2020

    Effect of Lactobacillus casei supplementation on clinical response, gut microbiota and faecal metabolites in patients with Parkinson’s disease: A randomized, double-blind, placebo-controlled trial

    X.D Yang, X.Q He, S.Q Xu, VV. Qian, Y. Zhang, YY. Song, Q. Xiao (Shanghai, China)

    Objective: To evaluate the effect of Lactobacillus casei strain Shirota (LcS) supplementation on symptoms, gut microbiota and faecal metabolites in patients with Parkinson's disease (PD).…
  • MDS Virtual Congress 2020

    Serum molecular markers and non-motor symptoms in Parkinson’s disease

    I. González-Aramburu, M. Sierra, J. Infante, S. Jesús Maestre, M. Aguilar, P. Pastor, J. Hernández Vara, S. Escalante, F.J Carrillo Padilla, M. Pueyo, J.M García Moreno, V. Puente, A. Crespo Cuevas, O. de Fábregues-Boixar, B. Solano Vila, T. de Deus-Fonticoba, P. Martínez Martín, P. Mir, D. Santos García (Santander, Spain)

    Objective: The aim of this study was to examine the association between several serum molecular markers and different measures of non-motor symptom burden in PD.…
  • MDS Virtual Congress 2020

    Prevalence of non-motor symptoms in Parkinson’s disease using the Movement Disorder Society-Non-Motor Rating Scale (MDS-NMS) and comparable scales

    C. Rodriguez-Blazquez, A. Schrag, D. Weintraub, A. Rizos, K.R Chaudhuri, P. Martinez-Martin (Madrid, Spain)

    Objective: To analyze the frequency and differences in distribution by sex and disease severity of non-motor symptoms (NMS) in patients with Parkinson’s disease (PD) using…
  • MDS Virtual Congress 2020

    Deep brain stimulation lead position impact on parkinsonian non-motor symptoms

    J. Bardoň, S. Kurčová, M. Chudáčková, P. Otruba, D. Krahulík, M. Nevrlý, P. Kaňovský, J. Zapletalová, J. Valošek, P. Hluštík (Olomouc, Czech Republic)

    Objective: This study evaluated the direct impact of localization of deep brain stimulation electrodes active contact within the different parts of subthalamic nucleus on improvement…
  • MDS Virtual Congress 2020

    Association between non-motor symptoms and severity of axial symptoms in patients with Parkinson’s disease

    H.A González-Usigli, A. Montaño-Serrano, I.E Berumen-Ocegueda, B. Contreras-Haro (Guadalajara, Mexico)

    Objective: Analyze the association between non-motor symptoms and severity of axial symptoms in patients with Parkinson’s disease. Background: Parkinson's disease (PD) is characterized by the…
  • MDS Virtual Congress 2020

    The non-declaration of musculoskeletal pain in Parkinson’s disease in patient-related outcome measures –The King’s experience

    K. Rukavina, M. Krbot Skoric, C. Borley, L. Batzu, A. Rizos, D. van Wamelen, K. Ray Chaudhuri (London, United Kingdom)

    Objective: To determine the usefulness of patient related outcome (PRO) measures in highlighting non-declaration of pain, a challenging non-motor symptom (NMS) of Parkinson’s disease (PD).…
  • MDS Virtual Congress 2020

    Effectiveness of Carbidopa/Levodopa Enteral Suspension (CLES) in Advanced Parkinson’s Disease (APD) Patients with Moderate to Severe Fatigue: Sub-group Analysis from PROviDE study

    S. Isaacson, J. Aldred, D. Cella, P. Kandukuri, N. Gupta, Y. Jalundhwala, P. Kukreja, I. Pan, R. Pahwa (North Chicago, IL, USA)

    Objective: To examine the effect of CLES at 12 months of follow-up in APD patients with moderate to severe fatigue. Background: Fatigue, one of the…
  • MDS Virtual Congress 2020

    Non-Motor Symptoms In Chinese Patients With Isolated Generalized Dystonia: A Case-Control Study

    S.L Li, X.H Wan, L. Wang, YY. Mai, L. Qiao, DD. Zhang (Beijing, China)

    Objective: To explore non-motor symtoms in Chinese patients with isolated generalized dystonia. Background: Previous studies have indicated that non-motor symptoms are primary problems in focal…
  • « Previous Page
  • 1
  • …
  • 22
  • 23
  • 24
  • 25
  • 26
  • …
  • 51
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Life expectancy with and without Parkinson’s disease in the general population
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • VIT-D and Tics Movement Disorder
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley